Suscripción a Biblioteca: Guest
Critical Reviews™ in Eukaryotic Gene Expression

Publicado 6 números por año

ISSN Imprimir: 1045-4403

ISSN En Línea: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Cellular Actions and Signaling by Endostatin

Volumen 12, Edición 3, 2002, 17 pages
DOI: 10.1615/CritRevEukaryotGeneExpr.v12.i3.20
Get accessGet access

SINOPSIS

The malignant transformation of a normal cell into a cancer cell requires no vasculature. Growth of solid tumors, however, requires angiogenesis to provide oxygen and nutrients to support cell proliferation. The switch from an avascular to a vascular phenotype is typically associated with acceleration of tumor growth. Antiangiogenic therapy, starving a tumor of its blood supply, is an attractive addition to the anticancer armamentarium. Animal tests of antiangiogenic therapy have shown remarkable potential. Initial human trials have proven antiangiogenic therapy to be remarkably nontoxic. Numerous antiangiogenic agents have been isolated as proteolytic fragments of endogenous polypeptides of the extracellular matrix. Endostatin was the first such antiangiogenic protein described and its potent antitumor effects in mice have generated wide interest. This review summarizes recent advances in endostatin biology and highlights new results on the cellular and subcellular mechanisms of endostatin action.

CITADO POR
  1. Schmidt Annette, Wenzel Daniela, Ferring Isabell, Kazemi Shohreh, Sasaki Takako, Hescheler J�rgen, Timpl Rupert, Addicks Klaus, Fleischmann Bernd K., Bloch Wilhelm, Influence of endostatin on embryonic vasculo- and angiogenesis, Developmental Dynamics, 230, 3, 2004. Crossref

  2. . N.A. Meguid, . E. Ashour, . A.A. Dardir, High Serum Endostatin Level in Egyptian Children with Down Syndrome: Gene Dosage Effect, Journal of Biological Sciences, 4, 3, 2004. Crossref

  3. Pradilla Gustavo, Legnani Federico G., Petrangolini Giovanna, Francescato Pierangelo, Chillemi Francesco, Tyler Betty M., Gaini Sergio M., Brem Henry, Olivi Alessandro, DiMeco Francesco, Local Delivery of a Synthetic Endostatin Fragment for the Treatment of Experimental Gliomas, Neurosurgery, 57, 5, 2005. Crossref

  4. Néstor T., Masckauchán H., Kitajewski Jan, Wnt pathways in angiogenesis, in Wnt Signaling in Embryonic Development, 17, 2007. Crossref

  5. Field-Ridley Aida, Heljasvaara Ritva, Pihlajaniemi Taina, Adatia Ian, Sun Christine, Keller Roberta L., Gong Wen Hui, Datar Sanjeev, Oishi Peter, Fineman Jeffrey R., Endostatin, an Inhibitor of Angiogenesis, Decreases After Bidirectional Superior Cavopulmonary Anastamosis, Pediatric Cardiology, 34, 2, 2013. Crossref

  6. Okada Muneyoshi, Oba Yoko, Yamawaki Hideyuki, Endostatin stimulates proliferation and migration of adult rat cardiac fibroblasts through PI3K/Akt pathway, European Journal of Pharmacology, 750, 2015. Crossref

  7. Poluzzi Chiara, Iozzo Renato V., Schaefer Liliana, Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers, Advanced Drug Delivery Reviews, 97, 2016. Crossref

  8. Abdollahi Amir, Hahnfeldt Philip, Maercker Christian, Gröne Hermann-Josef, Debus Juergen, Ansorge Wilhelm, Folkman Judah, Hlatky Lynn, Huber Peter E, Endostatin's Antiangiogenic Signaling Network, Molecular Cell, 13, 5, 2004. Crossref

  9. Mohajeri Abbas, Sanaei Sarvin, Kiafar Farhad, Fattahi Amir, Khalili Majid, Zarghami Nosratollah, The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering, Advanced Pharmaceutical Bulletin, 7, 1, 2017. Crossref

  10. Zhang Andrew Y., Teggatz Eric G., Zou Ai-Ping, Campbell William B., Li Pin-Lan, Endostatin uncouples NO and Ca2+response to bradykinin through enhanced O2−· production in the intact coronary endothelium, American Journal of Physiology-Heart and Circulatory Physiology, 288, 2, 2005. Crossref

  11. Schaffhauser Birgit, Veikkola Tanja, Strittmatter Karin, Antoniadis Helena, Alitalo Kari, Christofori Gerhard, Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice, Journal of Leukocyte Biology, 80, 4, 2006. Crossref

  12. Hasbum Asbiel, Quintanilla Jaqueline, Jr Juan A Amieva, Ding May-Hui, Levy Arkene, Chew Sue Anne, Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents, Future Medicinal Chemistry, 13, 4, 2021. Crossref

  13. Ricard-Blum Sylvie, Féraud Olivier, Lortat-Jacob Hugues, Rencurosi Anna, Fukai Naomi, Dkhissi Fatima, Vittet Daniel, Imberty Anne, Olsen Bjorn R., van der Rest Michel, Characterization of Endostatin Binding to Heparin and Heparan Sulfate by Surface Plasmon Resonance and Molecular Modeling, Journal of Biological Chemistry, 279, 4, 2004. Crossref

Próximos Artículos

PRMT6 promotes the immune evasion of gastric cancer via upregulating ANXA1 Liang Xu, Fenger Zhang, Binqi Yu, Shengnan Jia, Sunfu Fan PURPL promotes M2 macrophage polarization in lung cancer via regulating RBM4/xCT signaling Jipeng Guo, Chongwen Gong, Hao Wang SIAH1 promotes the pyroptosis of cardiomyocytes in diabetic cardiomyopathy via regulating IκB-α/NF-κB signaling Jinbin Wu, Yaoming Yan SLC7A2-mediated lysine catabolism inhibits immunosuppression in triple negative breast cancer Yuanyuan Sun, Yaqing Li, Chengying Jiang, Chenying Liu, Yuanming Song SIAH2-mediated degradation of ACSL4 inhibits the anti-tumor activity of CD8+ T cells in hepatocellular carcinoma Fangzheng Shu, Yuhua Shi, Xiangxiang Shan, Wenzhang Zha, Rengen Fan, Wanjiang Xue RBM15-mediated N6-methyl adenosine (m6A) modification of EZH2 drives the epithelial-mesenchymal transition of cervical cancer Ruixue Wang, Wenhua Tan Evidence-Based Storytelling and A Strategic Roadmap to Promote Cancer Prevention Via Adolescent HPV Vaccination in Northern New England Matthew Dugan, Gary Stein, Jan Carney, Sheila Clifford-Bova KDM4A-AS1 promotes cell proliferation, migration and invasion via the miR-4306/STX6 axis in hepatocellular carcinoma Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang HDAC1-mediated downregulation of NEU1 exacerbates the aggressiveness of cervical cancer Nanzi Xie, Sisi Mei, Changlan Dai, Wei Chen Effect of miR-26b-5p on progression of acute myeloid leukemia by regulating USP48-mediated Wnt/β-catenin pathway Yu Xie, Lin Tan, Kun Wu, Deyun Li, Chengping Li
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain